SK
Sumant Kulkarni Canaccord Genuity Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
CMPS
1
Compass Pathways
CMPS
$489M
| $5.10 | $15 |
194%
upside
| Buy | 1 month ago |
|
2
ATAI Life Sciences
ATAI
$977M
| $4.56 | $11 |
141%
upside
| Buy | 1 month ago |
|
3
Neurocrine Biosciences
NBIX
$13.9B
| $140.40 | $160 |
14%
upside
| Buy | 4 months ago |
|
4
Biogen
BIIB
$20.5B
| $139.94 | $220 |
57%
upside
| Buy | 4 months ago |
|
5
Zevra Therapeutics
ZVRA
$501M
| $8.93 | $25 |
180%
upside
| Buy | 5 months ago |
|
6
GH Research
GHRS
$872M
| $14.05 | $28 |
99%
upside
| Buy | 9 months ago |
|
7
MindMed
MNMD
$702M
| $9.23 | $14 |
52%
upside
| Buy | 11 months ago |
|
8
Stoke Therapeutics
STOK
$1.08B
| $19.63 | $20 |
2%
upside
| Buy | 1 year ago |
|
9
Acadia Pharmaceuticals
ACAD
$4.3B
| $25.50 | $33 |
29%
upside
| Buy | 1 year ago |
|
10
Biohaven
BHVN
$1.7B
| $16.07 | $150 |
833%
upside
| Buy | 4 years ago |
|